Continued Growth During 2023 – Milestones and Achievements
What a year 2023 has been. A year of remarkable growth and achievements, award-winning, and new standards in gmp manufacturing facilities.
Upperton Pharma Solutions Win’s Prestigious King’s Award for Enterprise: International Trade 2023
Upperton Pharma Solutions, a leading contract development and manufacturing organisation (CDMO) specialising in the development and manufacture of innovative drug formulations, has been announced as a winner of the King’s Award for Enterprise, International Trade. The King’s Award for Enterprise is a highly prestigious award for UK businesses who have demonstrated outstanding innovation in their industry. […]
Upperton completes build of new £15m development and GMP manufacturing facility
Leading UK contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions has completed the build of its new development and GMP manufacturing headquarters in Nottingham, UK. Situated less than two miles from Upperton’s current HQ, the facility ‘Trent Gateway’ houses ten new GMP manufacturing suites, quality control laboratories and formulation development with pilot plant capabilities. […]
Upperton Increases Oral Dosage Form Capabilities at its Nottingham HQ
20th April 2023 : Press Release Nottingham, UK, 20th April: Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK. Part of Upperton’s £15m investment program announced in January this year, the state-of-the-art facility has benefited from a […]
What’s New In 2023: Exciting Plans For Upperton Pharma Solutions
January 31st 2023 : Newsletter The New Year is always a time for looking ahead and 2023 will no doubt turn out to be a pivotal year in the Upperton Pharma Solutions growth story. In this Newsletter we will be previewing some of the exciting new plans that we have in store for ourselves and […]
Upperton’s new Nottingham facility
18th January 2023 Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has begun construction work for its new Development and GMP Manufacturing headquarters in Nottingham, UK. Working in close collaboration with its principal Design and Build contractor, T-SQUARED the team officially broke ground on the […]
2022: A year of unparalleled growth for Upperton
December 21st 2022 : Newsletter Traditionally at this time of year we like to offer Season’s Greetings to all our customers and friends and whilst doing so, look back over the years at some of the highlights in what has been an exceptionally busy (and successful) year for Upperton Pharma Solutions! Here are just a […]
Build of New Development and Manufacturing Facility
29th November 2022 – Press Release & Newsletter Upperton Pharma Solutions Appoints T-SQUARED for Design and Build of New Development and Manufacturing Facility Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has appointed T-SQUARED, UK based company, as the principal Design and Build contractor for […]
Upperton Launches ASAPprime® Shelf-Life Stability Testing
November 16th 2022 : Newsletter Upperton has made a significant investment in ASAPprime® software and hardware to enable the company to offer its clients state of the art stability testing. This exciting new platform can be used to generate robust, accelerated chemical stability data and is now being applied at all stages of the product […]
Successful MHRA Inspection & New Capsule Filling Technology
August 16th 2022 : Newsletter Upperton is delighted to announce that during the last week of July 2022 the UK MHRA conducted a routine, three day inspection of the GMP facility and Quality Control testing laboratories following which, no Critical or Major observations were raised. Speaking after the inspection, CEO Nikki Whitfield was quick to […]